Risk group criteria for tailoring adjuvant treatment in patients with endometrial cancer: a validation study of the Gynecologic Oncology Group criteria-Reference-Cited by-同舟云学术

Risk group criteria for tailoring adjuvant treatment in patients with endometrial cancer: a validation study of the Gynecologic Oncology Group criteria

Published:2015 Issue:1 Volume:26 Page:32
ISSN:2005-0380
Container-title:Journal of Gynecologic Oncology
language:en
Short-container-title:J Gynecol Oncol

Author:

Kong Tae Wook¹²,Chang Suk-Joon¹²,Paek Jiheum¹²,Lee Yonghee¹³,Chun Mison¹⁴,Ryu Hee-Sug¹²

Affiliation:

1. Gynecologic Cancer Center, Ajou University School of Medicine, Suwon, Korea.

2. Department of Obstetrics and Gynecology, Ajou University School of Medicine, Suwon, Korea.

3. Department of Pathology, Ajou University School of Medicine, Suwon, Korea.

4. Department of Radiation Oncology, Ajou University School of Medicine, Suwon, Korea.

Publisher

Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology and Colposcopy

Subject

Obstetrics and Gynaecology,Oncology,General Medicine

Link

http://synapse.koreamed.org/pdf/10.3802/jgo.2015.26.1.32

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Expression and Amplification of HER2 Has a Significant Impact on the Prognosis of Endometrial Carcinoma in Korean Patients;Journal of Clinical Medicine;2024-04-09

2. Independent Tissue-Based Biomarkers in Endometrioid Endometrial Cancer: Tumor Budding in Microsatellite Instability and WHO Grading in Copy-Number-Low Patients;Cancers;2023-07-28

3. Endometrial Carcinoma: Survival Analysis at a Tertiary Care Center in India;Indian Journal of Gynecologic Oncology;2022-11-17

4. Endometrial Cancer in Pre-Menopausal Women and Younger: Risk Factors and Outcome;International Journal of Environmental Research and Public Health;2022-07-25

5. Implementation of the 2021 molecular ESGO/ESTRO/ESP risk groups in endometrial cancer;Gynecologic Oncology;2021-08